Proline Injection

Generic Name: L-Proline
Drug Class: Non-essential, proteinogenic amino acid; substrate for collagen synthesis.
Route: Intravenous (IV), only as part of commercial or compounded amino-acid infusions.
Pharmaceutical Form:

• Mixed amino-acid PN solutions (5–20% AA)
• Not supplied as a single-component injection for standalone infusion.

Clinical Use:

• Component of parenteral nutrition to meet nitrogen and amino-acid requirements in patients unable to receive adequate enteral nutrition.
• Supports collagen formation, wound healing, and structural protein synthesis.

Key Metabolic Roles:

• Precursor and structural component of collagen (rich in proline/hydroxyproline).
• Participates in cellular redox balance through the proline-P5C cycle.
• Facilitates tissue repair, fibroblast activity, and extracellular matrix formation.

Important:
Proline is not dosed individually; its quantity is determined by the proportions within total amino-acid formulas. Distributed among the full amino-acid profile, it contributes to total nitrogen intake.

A. Adult PN Requirements

• Total amino acids: 1–2 g/kg/day (standard).
• Proline represents ~ 4–8% of amino-acid solution content depending on the formulation.
• This corresponds approximately to 40–80 mg/kg/day of proline (dependent on product composition).

B. Pediatric Requirements

• Infants/children: 2–3 g/kg/day of total amino acids.
• Proline proportion: Similar to adult formulas → ~ 80–160 mg/kg/day.

C. Increased Requirements

• Severe burns
• Trauma
• Major surgery
• Critically ill catabolic states
  (↑ Total amino acids to 1.5–2.5 g/kg/day → proportional rise in proline intake.)

D. Administration

• Infuse as part of a PN admixture through central venous access when osmolarity is high.
• DO NOT administer as IV push or single-amino-acid infusion.

Monitoring:

• Nitrogen balance
• Serum electrolytes
• Liver and renal function
• Blood glucose
• Triglycerides (if lipids included)

A. Collagen Synthesis

• Proline constitutes ~25% of the amino-acid residues in collagen (in combination with hydroxyproline).
• Essential to stabilization of the collagen triple helix, supporting:
  • Wound healing
  • Skin integrity
  • Tendon/ligament repair
  • Vascular structural strength

B. Proline ↔ Pyrroline-5-carboxylate (P5C) Cycle

• Redox shuttle between proline and P5C contributes to cellular NADP+/NADPH balance.
• Supports antioxidant systems and mitochondrial metabolism.

C. Energy Production

• Can be converted to glutamate → α-ketoglutarate → TCA cycle entry.
• Provides substrate during stress states.

D. Osmoprotection and Cellular Integrity

• Stabilizes protein folding
• Protects intracellular structures under stress conditions (oxidative or osmotic)

E. Support for Fibroblasts

Proline is required for fibroblast proliferation and extracellular matrix (ECM) formation.

Absolute Contraindications

1. Inborn errors of proline metabolism
   1. Hyperprolinemia type I & II
2. Severe metabolic disorders preventing proper amino-acid utilization
3. Hypersensitivity to amino-acid solutions (exceptionally rare)

Relative Contraindications

• Severe hepatic impairment: Reduced amino-acid clearance → risk of imbalance
• Renal failure: Risk of elevated BUN → adjust total amino acids
• Sepsis or hemodynamic instability: PN may need staged introduction
• Fluid/electrolyte disturbances: Correct abnormalities before PN initiation
• Refeeding syndrome risk: Initiate PN slowly in malnourished patients

Precautions

• Monitor for amino-acid imbalance or hyperaminoacidemia.
• Proline accumulation is uncommon but possible in hepatic failure.
• Long-term PN requires monitoring for trace element or vitamin imbalances.

Proline itself has minimal direct interactions, but PN admixtures involve complex compatibility considerations.

Drug Interactions

• None specific to proline
• However, metabolic interactions can occur due to:
  • Corticosteroids: Increased protein catabolism → altered AA requirements
  • Insulin therapy: Affects amino-acid uptake and protein synthesis
  • Acid–base modifying agents: Can alter amino-acid metabolism indirectly

Nutritional/PN Interactions

• Vitamin C deficiency: Impairs proline → hydroxyproline conversion, compromising collagen.
• Copper deficiency: Reduces lysyl oxidase activity → weak collagen crosslinking.
• Excessive glycine/alanine intake may alter amino-acid ratios and nitrogen balance.

Compatibility Considerations (PN admixtures)

• Must follow institutional PN compounding guidelines.
• Stability may be affected by:
  • Calcium/phosphate solubility
  • Lipid emulsion stability

Overall osmolarity

Most adverse reactions are related to total PN therapy, not proline specifically.

Common (PN-related)

• Nausea
• Vomiting
• Mild fever or infusion discomfort
• Elevated BUN (from total nitrogen load)
• Hyperglycemia (PN carbohydrate component)
• Electrolyte abnormalities

Proline-Specific Considerations

• Hyperprolinemia (rare without metabolic disorders)
  Symptoms may include:
  • Neurologic changes
  • Seizures (in genetic metabolic disorders)
  • Cognitive alterations
• Amino-acid imbalance if hepatic metabolism impaired

Severe (rare)

• Anaphylactoid reactions to amino-acid solutions
• Liver dysfunction with long-term high-dose PN
• Metabolic acidosis from improper PN formulation
• Refeeding syndrome (phosphate, potassium, magnesium shifts)

Pregnancy

• Proline is a normal nutritional requirement and is safe when delivered as part of PN.
• No teratogenic effects documented at nutritional doses.
• PN in pregnancy must be closely monitored for:
  • Glucose levels
  • Electrolytes
  • Adequate micronutrient intake
• Excessive amino-acid load should be avoided to prevent azotemia.

Breastfeeding

• Safe when used in PN at standard doses.
• No evidence of significant alteration of breast milk composition when maternal amino-acid levels are normal.
• Mothers on PN require monitoring for hydration, electrolytes, and calorie sufficiency.

For commercial amino-acid solutions containing proline:

• Temperature: Store at 20–25°C (68–77°F).
• Do not freeze; discard if frozen.
• Protection from light: Recommended for multi-component PN solutions.
• Inspect for:
  • Cloudiness
  • Precipitates
  • Leaks
• Use aseptic technique during compounding.
• Follow compounding policy for beyond-use dating (BUD):
  • Typically 24 hours at room temperature once prepared

Up to 7–9 days refrigerated for many PN formulations (depending on stability testing)

(Professional, authoritative medical sources – no URLs)

1. ASPEN (American Society for Parenteral and Enteral Nutrition). Guidelines for the Use of Parenteral Nutrition in Adults and Children.
2. ESPEN (European Society for Clinical Nutrition and Metabolism). Guidelines on Parenteral Nutrition.
3. S. Pharmacopeia (USP). Amino Acid Injection Monographs.
4. Morrison & Boyd. Clinical Nutrition: Parenteral Nutrition Handbook.
5. Nelson, Cox. Lehninger Principles of Biochemistry – Collagen and Amino-Acid Metabolism.
6. Medical Nutrition Therapy Textbook – PN Chapters.
7. Biochemistry of Collagen – Proline and Hydroxyproline Metabolism (Peer-reviewed sources).